Loading...
XSHE002513
Market cap259mUSD
Dec 25, Last price  
4.79CNY
1D
-4.77%
1Q
27.39%
Jan 2017
-70.43%
IPO
-75.37%
Name

Jiangsu Lanfeng Bio-chemical Co Ltd

Chart & Performance

D1W1MN
XSHE:002513 chart
P/E
—
P/S
1.09
EPS
—
Div Yield, %
0.64%
Shrs. gr., 5y
1.84%
Rev. gr., 5y
3.29%
Revenues
1.74b
+20.51%
550,598,351908,081,407627,542,583914,109,2531,143,272,6221,268,549,9511,372,077,3341,252,062,1681,010,416,2121,456,688,7061,850,640,8891,481,392,1331,504,434,6631,341,970,8911,443,932,1441,445,239,9891,741,628,407
Net income
0k
30,098,91697,825,67998,906,18176,821,29883,464,84559,230,65021,101,73400107,180,58135,446,7840014,823,557000
CFO
-383m
68,242,77096,752,923128,032,42070,521,86419,570,67358,878,64754,682,858127,973,626250,843,669335,700,62755,327,10173,297,827255,079,830128,305,65311,796,5570-383,302,095
Dividend
Jun 13, 20170.04 CNY/sh
Earnings
May 23, 2025

Profile

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.
URL
https://www.jslanfeng.com/
IPO date
Dec 03, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,741,628
20.51%
1,445,240
0.09%
1,443,932
7.60%
Cost of revenue
1,926,762
1,503,285
1,545,125
Unusual Expense (Income)
NOPBT
(185,133)
(58,045)
(101,193)
NOPBT Margin
Operating Taxes
(6,597)
73,724
Tax Rate
NOPAT
(178,537)
(131,769)
(101,193)
Net income
Dividends
(12,065)
Dividend yield
0.47%
Proceeds from repurchase of equity
(11,685)
101,550
BB yield
0.45%
-5.78%
Debt
Debt current
212,639
108,271
97,347
Long-term debt
409,402
263
576
Deferred revenue
114,107
6,161
8,963
Other long-term liabilities
106,300
72,543
4,207
Net debt
164,698
72,231
3,814
Cash flow
Cash from operating activities
(383,302)
11,797
CAPEX
Cash from investing activities
(536,786)
Cash from financing activities
925,944
47,828
FCF
(698,152)
102,132
620,701
Balance
Cash
457,343
24,002
84,570
Long term investments
2
12,300
9,539
Excess cash
370,262
21,913
Stockholders' equity
(1,497,100)
373,936
414,661
Invested Capital
2,589,732
539,934
753,895
ROIC
ROCE
EV
Common stock shares outstanding
372,865
340,086
340,086
Price
6.92
33.85%
5.17
3.61%
4.99
26.01%
Market cap
2,580,229
46.75%
1,758,246
3.61%
1,697,031
26.01%
EV
3,019,382
1,845,811
1,700,845
EBITDA
(86,912)
37,770
15,170
EV/EBITDA
48.87
112.12
Interest
29,689
13,555
22,598
Interest/NOPBT